Background
On September 26, 2019, Ethan Luken was administered methadone as part of his ongoing opioid abuse treatment, which he had begun one week earlier. Later that day, while driving in Terre Haute, Luken turned left and collided with Patrick Hawkins, who was operating a motorcycle. Hawkins suffered a broken neck, concussion, and road rash. Luken was subsequently convicted of operating a vehicle while intoxicated.
Hawkins filed a negligence complaint with the Indiana Department of Insurance (IDOI) and the trial court against nine anonymous defendants associated with Luken’s opioid treatment program. The defendants included the treatment program itself, the entity that held the state license and provided administrative services (the “Administrator”), the entity that managed day-to-day operations and medical services (the “Operator”), and several individual doctors and executives. Hawkins alleged the defendants negligently failed to warn Luken about the dangers of driving while taking methadone.
Hawkins sought a preliminary determination that his claims against five of the defendants were ordinary negligence claims, not subject to the Indiana Medical Malpractice Act (MMA). The defendants cross-moved for a determination that all claims fell under the MMA. The trial court granted a motion to strike certain evidence designated by Hawkins and ruled in favor of the defendants on the preliminary determination. Hawkins appealed.
The Court’s Holding
The Court of Appeals affirmed. On the motion to strike, the court assumed without deciding that the trial court erred in striking the probable cause affidavit and a federal treatment protocol excerpt, but held any such error was harmless because neither document addressed whether the defendants’ alleged negligence constituted “health care” under the MMA—the central legal question.
On the substantive question, the court applied the well-established framework for determining whether claims fall under the MMA. Under Indiana Code section 34-18-2-18, “malpractice” encompasses torts based on “health care or professional services” provided by a health care provider. The key inquiry is whether the alleged negligent conduct is connected to the nature of the patient-health care provider relationship, or instead is “demonstrably unrelated to the promotion of the plaintiff’s health or an exercise of the provider’s professional expertise, skill, or judgment.”
The court held that the defendants’ alleged failure to warn and instruct Luken about the risks of taking methadone—including the dangers of driving while on the medication—required the participation of health care professionals. Determining appropriate warnings about prescribed methadone’s side effects is not “unquestionably within the understanding of the average lay juror.” Because a medical professional is better equipped than a lay juror to evaluate compliance with the applicable standard of care, Hawkins’s claims sounded in medical malpractice, and the MMA applied.
Key Takeaways
- Claims based on an opioid treatment program’s alleged failure to warn patients about driving risks while taking prescribed methadone fall under Indiana’s Medical Malpractice Act. The duty to warn about medication side effects is inseparable from the health care professional’s exercise of medical judgment and expertise.
- The MMA applies even when the injured party is a third party (not the patient) and when the defendants include administrative and executive personnel—not just treating physicians. Indiana Code section 34-18-2-22 defines “patient” to include anyone with a claim arising from alleged malpractice, including derivative claims by third parties.
- Indiana courts distinguish between conduct that requires medical expertise to evaluate (covered by MMA) and conduct “unquestionably within the understanding of the average lay juror” (ordinary negligence). The touchstone is whether the standard of care prevalent in the local medical community must be applied to resolve the claim.
Why It Matters
The Indiana Medical Malpractice Act—one of Indiana’s most distinctive statutory frameworks—imposes procedural requirements that materially shape how claims are litigated, including mandatory filing with the IDOI, a medical review panel process, and damages caps. This decision confirms that the MMA’s reach extends to the growing area of opioid treatment litigation, meaning plaintiffs injured by patients receiving medication-assisted treatment must navigate the Act’s procedures rather than pursuing straightforward negligence claims.
For practitioners representing clients injured by impaired drivers, this ruling signals that when the impairment traces back to prescribed medications administered by a treatment program, the MMA will likely govern. This has significant strategic implications: the medical review panel process adds time and complexity, but the defendants’ obligations as qualified health care providers under the Act also require them to maintain professional liability insurance. Practitioners should carefully evaluate the nature of the alleged negligence at the outset to determine whether the claim must be routed through the MMA framework.